Who Paid My Doc
Bridion
Drug Neuroscience
NDC 0006-5423-15
General payments
$4,362,889
Research payments
$9,829,934
Through program year 2025, $4,362,889 in general payments and $9,829,934 in research payments were reported against Bridion (Neuroscience).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
14 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $503,828 | 24,709 |
| 2025 | Research | $709,320 | 19 |
| 2024 | General | $521,871 | 27,052 |
| 2024 | Research | $1,494,690 | 35 |
| 2023 | General | $502,874 | 24,295 |
| 2023 | Research | $1,572,439 | 55 |
| 2022 | General | $372,681 | 20,047 |
| 2022 | Research | $1,460,554 | 51 |
| 2021 | General | $333,060 | 17,362 |
| 2021 | Research | $908,537 | 71 |
| 2020 | General | $503,586 | 4,856 |
| 2020 | Research | $793,831 | 228 |
| 2019 | General | $1,624,990 | 11,095 |
| 2019 | Research | $2,890,564 | 940 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 117 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 54 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
129,416 general · 1,399 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.